Regulators are changing the way they look at labeling. The emphasis is on ensuring Marketing Authorization Holders have a linked up End-to-End (E2E) process...

January 17, 2017 Princeton, New Jersey:Navitas Launches Labeling Assessment Express to improve End-to-End labeling process and business performance

Why focus on End-to-End Labeling?

Regulators are changing the way they look at labeling. The emphasis is on ensuring Marketing Authorization Holders have a linked up End-to-End (E2E) process that delivers accurate, quality labeling information to the patient in a timely manner. This represents a paradigm shift from Drug Safety to Patient Safety, transforming labeling from a compliance focused activity to become one of the key mechanisms of getting timely benefit-risk information to patients and prescribers in a user friendly way.

Labeling is one of the most common areas for critical inspection findings. An effective E2E labeling process is essentially to safe guarding patient safety, ensuring regulatory compliance and protecting the company’s reputation through the avoidance of fines and unwanted media attention.

What is Labeling Assessment Express?

Labeling Assessment Express is a highly cost-effective diagnostic tool which provides a rapid read-out of the health of an E2E labeling system, without a long drawn-out project and with minimum disruption to the business.

The multi-dimensional read-out provides valuable insights on key E2E health indicators:

  • Process completeness and robustness
  • Governance
  • Organizational structure
  • Capabilities and capacity
  • Data management
  • Technologies
  • Inspection readiness

Our insights are driven through our extensive labeling experience and from Navitas’ labelnet®, a network of labeling professionals focused on best practices development for E2E labeling.

The output from Labeling Assessment Express is a report that includes:

  • A prioritized list of current gaps
  • A compliance Heatmap
  • Opportunities for improvement, including quick-wins and longer term initiatives
  • A shared, cross-functional vision for the future and roadmap for improvement

What does Labeling Assessment Express involve?

Labeling Assessment Express is an insight-led, cross-functional assessment by our experienced labeling consultants covering all relevant E2E labeling functions, including Pharmacovigilance, Regulatory Affairs, Artwork, Supply Chain, Quality, Medical Affairs and Commercial. Our experience working with stakeholders across multiple functions, and our ability to ‘speak the language’ and understand business challenges across different domains, enables us to conduct a comprehensive and holistic analysis in a compact timeframe.

Labeling Assessment Express is delivered through a combination of focused stakeholder interviews and discussions, and a single cross-functional alignment and process improvement workshop, to minimize the impact on your business.

Labeling Assessment Express generates the roadmap and the case for action, which defines the high level strategy, firms up the roadmap for implementation and builds the business case for change.

About Navitas:
The Navitas team has been assembled bringing together the proven expert teams of TAKE Life Sciences and WCI Consulting and, adding to this core, a range of experts from the worlds of Regulatory Affairs, Pharmacovigilance, Clinical Development, Technology, and Consulting.

We have built the Navitas team specifically to deliver subject matter expertise and insights to our clients, to develop pragmatic solutions together, and to support their deployment and operation. We deliver advice, process and technology solutions, and outsourcing services in Regulatory, Safety and Clinical.

We are proud that our legacy businesses have served the sector for over 20 years and have allowed us to work with 100 of the top Life Science companies. Our team has now grown to over 500 staff. For more information, visit www.navitas.net

Navitas also hosts labelnet, the industry’s unique and leading network for labeling professionals. labelnet focuses on the full lifecycle of label creation and maintenance; from core company information through to local and regional product information, artwork and distribution. labelnet is comprised of over 100 industry labeling executives from 28 leading pharmaceutical and biotechnology companies in the world. labelnet’s vision is to shape the future of labeling through community discussions, working groups, and bi-annual forums, supported by regular benchmarking of member performance and best practice sharing. labelnet guides the industry’s development of compelling, yet practical solutions to meet ever shifting regulatory requirements, while creating business value and meeting the needs of patients and prescribers. For more information, visit www.navitas.net/labelnet

 

Latest News

20
Apr2017

ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and...

Navitas welcomes the opportunity to provide comments on this Reflection Paper... Navitas welcomes the opportunity...

13
Apr2017

Navitas Life Sciences Augments Global Executive Management Team

Navitas Life Sciences announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer....

24
Jan2017

Navitas Networks announce Forum dates for Spring, 2017

The Navitas Networks are pleased to confirm the dates for our upcoming Spring forums... ...

17
Jan2017

Navitas Launches Labeling Assessment Express

Regulators are changing the way they look at labeling. The emphasis is on ensuring...

02
Nov2016

BioVectra chooses pharmaREADY for eCTD Solution

BioVectra has chosen pharmaREADY for its eCTD requirements. BioVectra, located in Canada, manufactures...

05
Oct2016

Navitas at DIA's 10th Annual Forum for Qualified Persons...

Navitas Principal Jeffrey Ho will present "Efficient content management for the compilation and...

04
Oct2016

News 2016

[row id="1" class="ROW_CLASS"] [col class="span12"] 02 Nov 2016 AbbVie and Navitas Present Case Study on the Evolution...

27
Sep2016

Navitas releases paper on CDISC, the standards and why the...

The FDA (and eventually, regulatory agencies from around the world) will require clinical data...

13
Sep2016

AbbVie and Navitas Present Case Study on the Evolution and...

At 10:30a.m. (East Coast Time) on September 22nd, Navitas and AbbVie will...

29
Jul2016

Navitas Networks announce Forum dates for Autumn, 2016

The Navitas Networks are pleased to confirm the dates for our upcoming Autumn forums....

12
Jul2016

Navitas Celebrates 100th pharmaREADY customer

pharmaREADY is Navitas’ intuitive and easy to use, fully integrated, regulatory compliant, web-based suite...

28
Jun2016

Navitas' PVTech Summit Defines Future Success

Navitas’ PVTech Summit was held on June 15th at the Hudson Hotel in New...

18
May2016

Navitas Welcomes Tara Baer to Navitas

Navitas is pleased to welcome Tara Baer, who joins Navitas' Regulatory Practice. With over...

18
May2016

Navitas Speaks at Sparta Connection in Orlando

David Gwyn, Navitas' Technology Practice lead, will unveil idmpREADY at the Sparta Connection conference...

14
Mar2016

Navitas Earns Speaking Sessions at DIA’s 52nd Annual Meeting

In two different sessions, Subject Matter Experts from Navitas will address new challenges facing...

09
Mar2016

Navitas is pleased to announce the introduction of our networks...

Navitas' inaugural pvindia meeting took place in Mumbai on Thursday 03 March, 2016. ...

25
Jan2016

Navitas Announces the Inaugural pvindia Forum

Navitas will soon be adding to our portfolio of industry leading networks with the...

18
Jan2016

Navitas Relaunches pharmaREADY.com

pharmaREADY.com is Navitas' next generation website for its fully integrated, regulatory compliant document management,...

14
Dec2015

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and...

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and Future of the Pharmaceutical...

03
Nov2015

The changing trends in drivers of life sciences R D...

Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales...